22.10.2024 10:15:05 CEST | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state

Oslo, 22 October 2024: Aqua Bio Technology ASA ("ABTEC" or "the Company") is
pleased to announce that Fredrik W. Henriksen has been appointed Chief Executive
Officer of the Company. Mr. Henriksen assumes his position on 1 December 2024,
and replaces Håvard Lindstrøm, who has served as CEO for more than 3 years.

 

"Håvard Lindstrøm started as CEO in 2021, when ABTEC had less than NOK 2m in
revenues. The Board would like to thank Håvard for leading the expansion
strategy of ABTEC over the last 3 years and growing the business from 2 small
entities to 16 subsidiaries today with a consolidated revenue stream of more
than NOK 500m. 

 

At the same time, we are very pleased to announce that Fredrik Henriksen has
accepted to sign on as our new CEO as the ABT Group is entering a new commercial
phase to utilize market potential both in B2B and B2C/D2C channels and value
chain optimalization, after a period of acquisitions and impressive expansion"
says Jon Olav Ødegård, Chair of the Board of Aqua Bio Technology ASA.

 

Mr. Henriksen has since 2016 served as Commercial Director in Norengros. He has
also 15 years in different start-ups prior to working within the sales and
distribution industry.

 

"Mr. Henriksen has a long and proven track record and is recognized as a solid
leader with distribution, strategy implementation and business development. I am
confident that he will further strengthen the company's great platform of
business areas and utilize opportunities for further growth in our value chain",
Mr. Ødegård continues.

 

"It's an honor for me, and I am proud to take over as CEO of Aqua Bio
Technology. I have already had the chance to follow the recent developments in
ABTEC and know the potential that lies in this organization and the vertical
integration of this industry. Executing on ABTECs strategy and growth plan will
be my single most important task to increase value for our customers and
shareholders", says Fredrik Henriksen.

 

For further information, please contact:

Jon Olav Ødegård

Chair of the Board of Directors

 

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

 * Jon Olav Ødegård, Chair of the Board of Directors, +4793632966,
   joo@hofsethbiocare.no 

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/18291121/5145/Download%20announce
ment%20as%20PDF.pdf